Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Aulos Bioscience, Inc.
ImmunityBio, Inc.
NRG Oncology
Ocellaris Pharma, Inc.
EMD Serono
Hospital of Macerata
Pfizer
Exelixis
University of Utah
Pfizer
Pfizer
Fate Therapeutics
Jules Bordet Institute
National Institutes of Health Clinical Center (CC)
Pfizer
Hoosier Cancer Research Network
The Netherlands Cancer Institute